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Loss of retinal ganglion cells (RGCs) accounts for
visual function deficits after optic nerve injury, but
how axonal insults lead to neuronal death remains
elusive. By using an optic nerve crush model that
results in the death of the majority of RGCs, we
demonstrate that axotomy inducesdifferential activa-
tion of distinct pathways of the unfolded protein
response in axotomized RGCs. Optic nerve injury
provokes a sustained CCAAT/enhancer binding
homologous protein (CHOP) upregulation, and dele-
tion of CHOP promotes RGC survival. In contrast,
IRE/XBP-1 is only transiently activated, and forced
XBP-1 activation dramatically protects RGCs from
axon injury-induced death. Importantly, such differ-
ential activations of CHOP and XBP-1 and their
distinct effects on neuronal cell death are also ob-
served in RGCs with other types of axonal insults,
suchasvincristine treatmentand intraocularpressure
elevation, suggesting a new protective strategy for
neurodegeneration associated with axonal damage.
INTRODUCTION
Retinal ganglion cells (RGCs) are the only neurons that relay
visual information from the retina to the brain. These neurons
are highly vulnerable when their axons, which collectively form
the optic nerve, are damaged (Levin, 1997). For example, trau-
matic optic nerve injury and subsequent loss of RGCs often
occur in the setting of head injury, as a consequence of traffic
accidents or falls. In rodents, the majority of RGCs undergo
cell death around 2 weeks after intraorbital optic nerve injury(Berkelaar et al., 1994; McKernan and Cotter, 2007; Selle´s-
Navarro et al., 2001), creating a first hurdle for successful neural
repair. In addition to optic nerve trauma, the retinal pathology of
different types of optic neuropathy, in particular glaucoma, is
also characterized by selective RGC loss (Howell et al., 2007;
Kerrigan et al., 1997; Libby et al., 2005; Quigley, 1993; Quigley
et al., 1995; Weinreb and Khaw, 2004). In these conditions,
RGC loss has been attributed to apoptotic death (Howell et al.,
2007; Kerrigan et al., 1997; Libby et al., 2005; Quigley, 1993;
Quigley et al., 1995; Weinreb and Khaw, 2004; Qu et al., 2010).
However, RGC apoptosis may occur as the last step in these
diseases, so that targeting apoptotic effectors may not be
an efficient strategy for therapy. Thus, deciphering the key
upstream signals that trigger the apoptotic cascade in RGCs
should provide important targets for therapeutic interventions.
Multiple stimuli, such as hypoxia, nutrient deprivation, viral
infection, and disturbance of calcium levels, can directly or indi-
rectly cause accumulation of unfolded or misfolded proteins in
the endoplasmic reticulum (ER), triggering an ER stress condi-
tion which leads to an evolutionarily conserved unfolded protein
response (UPR) (Ron and Walter, 2007). The UPR has been
proposed to be a protective mechanism that limits ER protein
loading by inhibiting protein translation, facilitates protein folding
through increasing the expression of ER chaperones, and
removes misfolded proteins from the ER through degradation.
However, prolonged and unrestrained ER stress could lead to
the activation of proapoptotic signaling pathways.
In mammals, the UPR includes three signal-transduction path-
ways initiated by three ER-resident stress-sensing proteins:
protein kinase RNA-like ER kinase (PERK), inositol-requiring
protein-1 (IRE1), and activating transcription factor-6 (ATF6).
PERK activation leads to the phosphorylation of the eukaryotic
inactivation factor 2a (eIF2a). While suppressing general protein
translation, eIF2a phosphorylation also promotes the selective
translation of some mRNAs, such as ATF4, a transcription factor
that induces CCAAT/enhancer binding homologous proteinNeuron 73, 445–452, February 9, 2012 ª2012 Elsevier Inc. 445
Figure 1. Optic Nerve Injury Induces UPR in Adult RGCs
(A) Quantification of expression of different molecules in RGCs detected by qRT-PCR. Each sample was run in quadruplicate in each assay. GAPDHwas used as
the endogenous control. CL, contralateral uninjured eye. *p < 0.01, paired Student’s t test. Data are presented asmeans ± SEM and n = 6. (B) In situ hybridization
(ISH) results showing the expression of CHOP and BiP in the ganglion cell layer of adult mouse retinas. Scale bar represents 20 mm. 3 dpc, 3 days postcrush; GCL,
ganglion cell layer. (C) Immunohistochemical analysis for CHOP or TUJ1 immunoreactivity in retinal sections. Scale bar represents 20 mm. (D) Detection of
unspliced and spliced XBP-1 mRNA (XBP-1u or XBP-1s) by RT-PCR. The mRNAs were prepared from retrograde-labeled and FACS-purified adult RGCs from
retinas 1 day, 3 days postcrush (1 dpc, 3 dpc), contralateral (CL) eyes, and naive eyes. See also Figure S2.
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stress marker (Fels and Koumenis, 2006; Harding et al., 2003).
On the other hand, the site-specific endoribonuclease function
of IRE1 mediates the specific splicing of XBP-1 mRNA to
generate an active (spliced) form XBP-1s (Calfon et al., 2002;
Sidrauski andWalter, 1997; Yoshida et al., 2001). XBP-1s targets
a set of genes that increases the ER protein-folding capacity and
facilitates degradation of misfolded proteins (Lee et al., 2003;
Shaffer et al., 2004). Although IRE/XBP-1 has been proposed
to be protective, the in vivo effect of XBP-1 on neuroprotection
is less clear. In fact, it was shown that XBP-1 deletion in the
nervous system (XBP-1flox/flox mice crossed with nestin-Cre
mice) could extend lifespan of transgenic mice expressing
a mutant SOD1, an amyotrophic lateral sclerosis model, by
enhancing autophagy, and thus degradation of the mutant
SOD1 protein in vivo (Hetz et al., 2009).
In our analysis of the mechanisms for reduced protein
synthesis ability in axotomized RGCs in adult mice (Park et al.,
2008), we found that axotomized RGCs showed signs of UPR,
indicating that ER stress is induced in these neurons. In fact,
ER structures that are distributed along entire lengths of axons
and are connected with those in the neuronal somas might
possess the unique properties of transducing the local axonal
signals to the soma of individual neurons. However, despite
previous reports about ER stress responses in neurons (Aoki
et al., 2002; Saxena et al., 2009), it is unknown how these path-
ways are activated and, more importantly, what the functional
consequences are. Thus, we decided to assess axotomy-trig-
gered UPR in depth using in vivo mouse models.446 Neuron 73, 445–452, February 9, 2012 ª2012 Elsevier Inc.RESULTS
Axotomy Triggers UPR in RGCs
CHOP, a key downstream target of PERK pathway, has been
linked to apoptosis after ER stress in multiple disease models
(Pennuto et al., 2008; Puthalakath et al., 2007; Silva et al.,
2005; Song et al., 2008; Zinszner et al., 1998). To assess the
expression of CHOP in intact and axotomized RGCs, we purified
RGCs from wild-type rats with or without optic nerve crush by
retrograde labeling and fluorescence-activated cell sorting
(FACS) (Park et al., 2008). Through the use of the mRNA isolated
from purified RGCs, quantitative real-time PCR (qRT-PCR)
analysis showed increased expression of CHOP and other ER
stress markers, such as GADD45a (Lee et al., 2003), in axotom-
ized RGCs (Figure 1A), which was further confirmed by both
in situ hybridization and immunohistochemical analysis in
retinal sections (Figures 1B and 1C). In contrast, Redd1/2, the
inhibitors of the mTOR pathway induced by hypoxia (Brugarolas
et al., 2004), and Hsp60, a mitochondria stress chaperone
(Deocaris et al., 2006), were not induced by axotomy in RGCs
(Figure 1A).
We also examined the activation of other UPR targets in axo-
tomized RGCs. Because XBP-1 splicing has been considered as
a hallmark of UPR (Calfon et al., 2002; Sidrauski and Walter,
1997; Yoshida et al., 2001), we examined whether the splicing
product of XBP-1 (XBP-1s) could be detected in RGCs after
optic nerve injury. By RT-PCR with mRNAs from purified
RGCs, we found that a small amount of XBP-1s appeared in
the RGCs obtained at both 1 and 3 days after optic nerve crush,
Figure 2. CHOP KO, but Not XBP-1 KO, Increases
RGC Survival after Optic Nerve Injury
(A and C) Representative images of fluorescent photo-
micrographs of flat-mounted retinas showing surviving
TUJ1+ RGCs at 2 weeks after injury in WT mice and
CHOP KO mice (A) and XBP-1flox/flox control mice (no
AAV-Cre) and XBP-1flox/flox mice injected with AAV-Cre
(C). CL, contralateral uninjured eye. Scale bar represents
20 mm. (B and D) Quantification of surviving RGCs,
represented as percentage of TUJ1+ RGCs, compared
to the uninjured contralateral retinas, in CHOP KO mice
(B) or XBP-1 KO mice (D). *p < 0.01, Student’s t test.
Data are presented as means ± SEM and n = 6. See also
Figure S1.
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upregulation of BiP, a XBP-1 target (Lee et al., 2003), was seen at
3 days postinjury (Figures 1A and 1B), consistent with a modest
activation of the IRE1/XBP-1 pathway in axotomized RGCs.
These results suggested that optic nerve injury triggers robust
CHOP induction and modest XBP-1 activation in axotomized
RGCs.
CHOP Deficiency Promotes RGC Survival
We next examined whether UPR activation contributes to
RGC cell death after axotomy. We thus performed optic nerve
crush in CHOP knockout (KO) mice (Marciniak et al., 2004)
and control mice and analyzed the extents of RGC survival by
counting survived TUJ1-positive RGCs at different postinjury
points (Park et al., 2008). Consistent with the notion that CHOP
could act as a proapoptotic molecule, we found significant
increases of RGC survival in CHOP KO mice, compared to
wild-type (WT) control mice, after injury (Figure 2A). As shown
in Figure 2B, 52% of RGC survived in CHOP KO mice 2 weeks
after optic nerve crush, compared to 24% RGC survival in WT
mice. Therefore, these results suggest that CHOP activation
is a critical mechanism that mediates axotomy-induced RGC
death.
Lack of Significant Effects of XBP-1 Deletion
on RGC Survival
Based on the observation of XBP-1 activation, albeit to amodest
level, in axotomized RGCs (Figure 1D), we examined the effects
of genetic deletion of XBP-1 in RGCs on RGC survival after optic
nerve injury. Because XBP-1 germline KO is embryonic lethal
(Reimold et al., 2000), we utilized an adeno-associated virus
(AAV)-Cre-assisted conditional knockout strategy (Park et al.,
2008) to delete XBP-1 in adult RGCs of XBP-1flox/flox mice
(Hetz et al., 2008). Intravitreal injection of AAV-Cre has previouslyNeuron 73, 44been shown to delete a floxed gene in most
RGC (Park et al., 2008). By in situ hybridization,
we further verified the lack of XBP-1 expression
in the RGCs of XBP-1flox/flox mice with AAV-Cre
injection (see Figure S1A available online). As
shown in Figures 2C and 2D, there was no
significant difference in RGC survival between
XBP-1-deleted mice and control mice afterinjury, suggesting that XBP-1 deletion does not affect axot-
omy-triggered RGC death.
Differential Activation of CHOP and XBP-1 in RGCs
after Axonal Insults
To explore possible mechanisms for differential effects of CHOP
and XBP-1 deletion on RGC death, we monitored the temporal
expression levels of XBP-1s and CHOP in axotomized RGCs
during the first week after axotomy (because of difficulty in col-
lecting RGCs at later time points due to massive RGC loss).
XBP-1s level was elevated in RGCs isolated from animals at 3
and 5 days after optic nerve crush, but reduced at 7 days post-
injury (Figure S1B). In addition to being transient, XBP-1 activa-
tion in axotomized RGCs is also modest, when compared with
the amount of XBP-1s in cells treated with thapsigargin, an agent
that induces ER stress by depletion of luminal calcium stores
(Figure S1B). In contrast, CHOP expression was persistently
high during the time course studied (Figure S1C). These results
suggest that optic nerve injury triggers differential activation
of different UPR pathways: although CHOP is robustly and
persistently activated, XBP-1 is only transiently and modestly
activated. Because previous studies in cultured nonneuronal
cells suggested that the duration of IRE1/XBP-1 activation corre-
lates with its protective effects (Lin et al., 2007), the transient
activation of IRE1/XBP-1 in axotomized RGCs might explain
the failure of XBP-1 knockout in affecting RGC survival.
To assess whether differential activation of CHOP and XBP-1
occurs in other types of axonal damage, we intravitreously
injected vincristine, a microtubule destabilizer which preferen-
tially induces axonal degeneration (Silva et al., 2006; Vohra
et al., 2010). As shown in Figure S2, vincristine triggered CHOP
upregulation, but not XBP-1 splicing (detected by RT-PCR using
mRNAs of whole retina or isolated RGCs), at 1 day postinjection.
In contrast, both CHOP upregulation (Figure S2A) and XBP-15–452, February 9, 2012 ª2012 Elsevier Inc. 447
Figure 3. The Effects of XBP-1s Overexpression on RGC Survival after Optic Nerve Injury
(A) Representative images of flat-mounted retinas showing surviving TUJ1+ RGCs at 2 weeks postinjury in WT control mice injected with AAV-GFP or AAV-
XBP-1s or CHOP KO mice injected with AAV-XBP-1s. Anti-HA antibody is used to indicate RGCs injected with AAVs expressing HA-tagged XBP-1s. Scale bar
represents 20 mm. (B) Quantification of TUJ1+ RGCs represented as percentage of TUJ1+ RGCs compared to the uninjured contralateral retinas. Data are
presented as means ± SEM and n = 6. *p < 0.01, one-way analysis of variance (ANOVA) and Tukey’s multiple comparison test. (C) Left: immunostaining of active
caspase-3 at 3 days postinjury in WT mice, CHOP KOmice, and AAV-XBP-1s injected mice. CL, contralateral uninjured eye. Scale bar represents 20 mm. Right:
quantification of caspase-3+ RGCs per section. Data are presented asmeans ± SEM and n = 4. *p < 0.01, one-way ANOVA and Tukey’smultiple comparison test.
(D) In situ hybridization results showing the expression of BiP andGADD45a in the ganglion cell layer (GCL) ofWTmice,CHOPKOmice, and AAV-XBP-1s injected
mouse retinas 3 days postinjury. CL: contralateral uninjured eye. Scale bar represents 20 mm. See also Figure S3.
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whole retinas) were induced by similarly applied thapsigargin,
which presumably acts on both axons and cell bodies. Thus,
instead of simultaneous activation of all UPR pathways that
occur in nonneuronal cells, axonal insults preferentially lead to
the activation of CHOP, but not XBP-1, in RGCs. In comparison
with other cell types, a striking feature of neurons is the unique
compartmentation in which the axon is separated from the
soma. It is conceivable that certain unique properties of the
axonal compartment, such as the lack of detectable mRNAs
and the long distance to the soma,might contribute to the limited
XBP-1 activation in axotomized adult RGCs.
Overexpressing XBP-1s Promotes RGC Survival
after Optic Nerve Injury
Limited XBP-1 activation in axotomized RGCs suggests the
possibility that forced XBP-1 activation might alter RGC survival
after optic nerve injury. To test this, we overexpressed an active
hemagglutinin (HA)-tagged XBP-1s in RGCs using recombinant448 Neuron 73, 445–452, February 9, 2012 ª2012 Elsevier Inc.AAVs in WT and CHOP KO mice. As shown in Figure S3A,
approximately 50% and 80% of TUJ1-positive RGCs were
stained with an anti-HA antibody 1 or 2 weeks after injection of
AAV-XBP-1s-HA, respectively. Then, we performed optic nerve
injury at 2 weeks after the intravitreal injection of AAVs. As shown
in Figures 3A and 3B, AAV-XBP-1s dramatically increased RGC
survival in bothWTmice andCHOPKOmice. In comparison with
approximately 20% RGC survival in AAV-green fluorescent
protein (GFP) injected control mice, WT mice with XBP-1s
overexpression showed approximately 64% RGCs survival at
2 weeks after injury (Figure 3B).CHOP KO could further enhance
the survival effects of XBP-1s overexpression, because 82%
RGCs survived in CHOP KO mice with XBP-1s overexpression
2 weeks after optic nerve crush (Figure 3B). Taken together,
these results suggest that XBP-1 and CHOP play opposite roles
in controlling neuronal survival after axonal injury.
Because failure of RGC axon regeneration is another major
feature of optic nerve damage, we also determined whether
increase of RGC survival improves axon regeneration. We
Neuron
ER Stress and Retinal Ganglion Cell Lossanterogradely labeled the RGC axons with neuronal tracer
cholera toxin B; however, in all of these animals, we failed to
observe any enhancement of optic nerve regeneration (Fig-
ure S3B), suggesting that UPR selectively affects neuronal
survival, but not axon regeneration.
Independent Action of XBP-1 andCHOPonRGCSurvival
We next examined possible interactions between XBP-1 and
CHOP in their effects on neuronal survival. Although the
promoter of CHOP contains a putative XBP-1 binding site (Roy
and Lee, 1999; Urano et al., 2000), we failed to observe signifi-
cant change of CHOP expression in intact or injured RGCs
upon AAV-assisted XBP-1s overexpression (Figures S3C and
S3D). Conversely, XBP-1s induction was not affected by
CHOP knockout (Figure S3E), suggesting independent regula-
tion of XBP-1 and CHOP activation or expression in neurons.
Both CHOP KO and XBP-1s overexpression reduced the
extent of injury-induced RGC apoptosis, as indicated by TUNEL
(data not shown) and active caspase-3 staining (Figure 3C). We
then assessed whether similar down-stream effectors might
contribute to the effects of CHOP KO and XBP-1s overexpres-
sion on neuronal survival. As shown in Figure 3D, neither
CHOP KO nor XBP-1s overexpression altered axotomy-induced
expression of GADD45a. However, XBP-1s overexpression,
but not CHOP KO, significantly induced the expression of the
ER chaperon BiP (Lee et al., 2003), suggesting that different
downstream mechanisms might be involved in the effects of
XBP-1s and CHOP KO on regulating RGC apoptosis after axon
injury.
The Effect of CHOP and XBP-1 on Glaucomatous
RGC Degeneration
Glaucoma is a common form of optic neuropathy that is charac-
terized by progressive RGC degeneration (Howell et al., 2007;
Kerrigan et al., 1997; Libby et al., 2005; Quigley, 1993; Quigley
et al., 1995; Weinreb and Khaw, 2004). Elevated intraocular
pressure (IOP) is the most recognized risk factor for primary
open-angle glaucoma (Quigley, 1993). Studies in primates
demonstrate that experimentally elevated IOP results in axonal
transport obstruction and nerve damage at the optic nerve
head, followed by RGC loss (Minckler et al., 1977). Moreover, it
was shown that elevated IOP induces CHOP expression in
RGCs (Doh et al., 2010). We thus attempted to examine whether
manipulation of the UPR pathways could protect RGCs in
a mouse model of glaucoma in which IOP was elevated by injec-
tion of microbeads into the anterior chamber of adult mice to
block aqueous outflow (the contralateral eyes with sham injec-
tion served as controls) (Sappington et al., 2010). This estab-
lished procedure has been shown to induce many features of
glaucoma, such as optic nerve head cupping, optic nerve degen-
eration, and RGC loss (Chen et al., 2010; Sappington et al.,
2010).
A first anterior chamber injection of microbeads induced IOP
elevation to 20–25 mmHg, about two times higher than normal,
for 4 weeks, and then elevation was maintained for another
4 weeks with a second microbead injection, compared to
a steady level of 10 mmHg of IOP in the control eyes (Figure 4A).
As a result, approximately 42% RGCs are lost at 8 weeks aftermicrobead injection in WT mice (Figures 4B and 4C). In these
animals, at 7 days after microbead injection, there was a marked
increase in CHOP expression in RGCs assessed by immuno-
staining (Figure S4A). However, we failed to detect the spliced
form of XBP-1 at all the time points studied (3, 5, and 7 days after
microbead injection) (data not shown), suggesting that similar to
optic nerve injury, IOP elevation triggers differential activation of
different UPR pathways in RGCs.
Importantly, both CHOP KO and XBP-1s overexpression
significantly reduced RGC death. The combination of CHOP
KO and XBP-1s overexpression showed a trend of further
protection, but the extent of the protection did not reach the level
of statistical significance as compared to CHOP KO or XBP-1s
overexpression alone (Figures 4B and 4C). These protective
effects are not due to the alteration of the IOP levels, because
microbead injection induced similar degrees of IOP elevation in
all experimental groups (Figure S4B). Because brain-derived
neurotrophic factor (BDNF) has been shown to be protective
for RGCs (Cohen-Cory and Fraser, 1994; Mansour-Robaey
et al., 1994), we simultaneously applied BDNF and XBP-1s to
the eyes of animals that received an optic nerve crush injury
(Figure S4C) or were subjected to IOP elevation (Figure S4D).
Although BDNF alone protected RGCs to some extent, it did
not lead to a significant further enhancement of RGC survival
in any of these models when it was combined with XBP-1s over-
expression. The mechanistic interactions between UPR and
neurotrophin pathways remain to be further elucidated.
To mimic a clinically relevant scenario, we also examined
whether a delayed expression of XBP-1s can be protective for
RGCs in the IOP-elevated model. We thus increased IOP by
microbead injection followed by introduction of AAV-XBP-1s
1 or 7 days later. Because AAV-mediated gene expression in
RGCs is normally peaked at 2 weeks after infection (Martin
et al., 2002; Park et al., 2008), XBP-1s expression in RGCs is
likely to occur 2–3 weeks after IOP elevation. Interestingly,
such delayed AAV-XBP-1s expression still showed significant
protective effects on RGCs (Figures 4D and 4E), suggesting
that forced XBP-1s expression might be a promising therapeutic
approach for RGC degeneration in glaucoma.
DISCUSSION
A predominant hypothesis holds that ER stress activates all
UPR pathways, thereby simultaneously producing antagonistic
outputs that can be both protective and harmful to cells; only
unresolved ER stress results in cell death (Ron and Walter,
2007). Although these principles might be applicable to non-
neuronal cells, the results from this study suggest a different
scenario for neurons, at least adult RGCs. By using different
axonal damage models, we demonstrate that diverse UPR path-
ways are differentially activated in the affected RGCs and in fact
have opposite effects on neuronal survival. These results reveal
a potentially important logic of protecting RGCs by differentially
manipulating the UPR pathways.
In all models, we observed robust and persistent CHOP induc-
tion. Consistent with previous studies (Pennuto et al., 2008;
Puthalakath et al., 2007; Silva et al., 2005; Song et al., 2008;
Zinszner et al., 1998), CHOP induction might be an importantNeuron 73, 445–452, February 9, 2012 ª2012 Elsevier Inc. 449
Figure 4. CHOP Deletion and XBP-1s Overexpression Protect RGCs after IOP Elevation
(A)Measured IOP levels in the eyes of thewild-typemicewith saline injection (sham eyes) ormicrobead injection (injected eyes). Whereas the sham eyes exhibited
a steady level of IOP at 10.0 ± 1.5mmHg (n = 8), a single injection induced IOP elevation that lasts for 4weeks, and a second dose ofmicrobead injection on day 24
(arrow) could maintain elevated IOP levels for 8 weeks (n = 8). (B) Quantification of surviving RGCs, represented as percentage of TUJ1+ RGCs, compared to the
uninjured contralateral retinas, in each group at 8 weeks after IOP elevation. Data are presented as means ± SEM and n = 8. *p < 0.01; one-way ANOVA and
Tukey’s multiple comparison test. (C) Representative images of TUJ1 (red) and HA (green) labeling in flat-mounted retinas from uninjected contralateral eyes and
from those eyes 8 weeks after IOP elevation. AAV-XBP-1s was injected 2 weeks before IOP elevation. Scale bar represents 20 mm. (D) Representative images
of TUJ1 (red) and GFP or HA (green) labeling in flat-mounted retinas from uninjected contralateral eyes and from those eyes 8 weeks after IOP elevation. AAV-
XBP-1s was injected 1 day after IOP elevation. Scale bar represents 20 mm. (E) Quantification of surviving RGCs, represented as percentage of TUJ1+ RGCs,
compared to the uninjured contralateral retinas, in each group at 8 weeks after IOP elevation. AAV-XBP-1s was injected 1 day or 7 days after IOP elevation. Data
are presented as means ± SEM and n = 8. *p < 0.01; Student’s t test. See also Figure S4.
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same models, IRE/XBP-1 pathway either is not activated or is
only transiently activated, consistent with the lack of phenotypes
of XBP-1 deletion on neuronal death. Directly overexpressing an
active XBP-1 in the adult RGCs protects RGCs from apoptotic
death after both acute and chronic insults, indicating a neuropro-
tective role of XBP-1 in RGC survival.
Probably, all of the ER stress sensors, including IRE1, become
activated when axon injury occurs. The unique properties of the
axonal compartments, such as length and limited mRNAs local-
ization, might explain the different UPR activation patterns in
adult RGCs (this study) and nonneuronal cells (Ron and Walter,
2007). For example, because activation of XBP-1, a protective
arm of UPR pathways, requires IRE1-mediated mRNA splicing
(Yoshida et al., 2001), little XBP-1 mRNAs in the axonal com-
partment in adult neurons might limit the activation of this
pathway in the axon. As a consequence, axonal insults result450 Neuron 73, 445–452, February 9, 2012 ª2012 Elsevier Inc.in the overweight of proapoptotic UPR activation, which might
contribute to irreversible neuronal death associated with trau-
matic optic nerve injury, glaucoma, and perhaps other types of
neuropathies. In light of recent successes in AAV-mediated
gene therapy in retinal diseases (Busskamp et al., 2010; Tan
et al., 2009), our resultsmay provide potentially importantmolec-
ular targets for neuroprotective strategies for optic nerve injury
and diseases.
EXPERIMENTAL PROCEDURES
Detailed methods and materials are in the Supplemental Experimental
Procedures.
Mice
CHOP KO and C57BL/6 mice and Sprague-Dawley rats were purchased from
the Jackson Laboratory. XBP-1flox/flox mice were described as before (Hetz
et al., 2008). All experimental procedures were performed in compliance
Neuron
ER Stress and Retinal Ganglion Cell Losswith animal protocols approved by the Institutional Animal Care and Use
Committees at Children’s Hospital, Boston.
Intravitreal Injection and Optic Nerve Crush
For each intravitreal injection, the micropipette was inserted in peripheral
retina just behind the ora serrata and was deliberately angled to avoid damage
to the lens. The left optic nerve was exposed intraorbitally and crushed with
forceps for 5 s approximately 1 mm behind the optic disc, as described previ-
ously (Park et al., 2008).
RGC Purification
For retrograde labeling of RGCs, the superior colliculi of adult Sprague-Dawley
rats were injected with DiI (2% in DMF). Eyes were removed and retinas were
prepared for the cell dissociation procedures 5–7 days after surgery. Dissoci-
ated retinal cells were used for FACS sorting to collect DiI-positive RGC cells.
RT-PCR and qRT-PCR
Total RNA was extracted from purified RGCs and was reverse transcribed to
cDNA, which was amplified by PCR using specific primers for XBP-1u or XBP-
1s. For qRT-PCR, total RNA (50–100 ng) was reverse transcribed and amplified
with TagMan predesigned real-time PCR assays. Each sample was run in
quadruplicate in each assay. GADPH was used as the endogenous control.
Immunohistochemistry and In Situ Hybridization
Immunostaining and in situ hybridization were performed following standard
protocols (Park et al., 2008). Retinal sections were incubated with primary anti-
bodies overnight at 4C and washed three times for 15 min each with PBS.
Secondary antibodies were then applied and incubated for 1 hr at room
temperature. Sections were again washed three times for 15 min each with
PBS before a coverslip was attached with Fluoromount-G. For RGC counting,
whole-mount retinas were immunostained with the TUJ1 antibody, and 6–9
fields were randomly sampled from peripheral region per retina to estimate
RGC survival. The people who counted the cells were blinded with the treat-
ment of the samples.
AAV Production
For making AAV2-XBP-1s, we inserted the cDNA of XBP-1s-3HA downstream
of the CMV promoter/b-globin intron enhancer in the vector pAAVsc CB6. RBG
and viral preparation was made by UMass Gene Therapy Center. The titer
determined by silver staining is 1.85 3 1012.
Induction of Chronic IOP Elevation in Mice
The procedure has been described in detail recently (Chen et al., 2010;
Sappington et al., 2010). Briefly, in anesthetized mice, elevation of IOP was
induced unilaterally in adult mice by anterior chamber injection of 2 ml fluores-
cent polystyrene microspheres. The control group received 2 ml saline to the
anterior chamber. Mice received a second injection of microbeads at 4 weeks
after the first injection. The mice with corneal opacity or signs of inflammation
in the anterior chamber (e.g., cloudy anterior chamber) were excluded from
further analysis. IOP was measured every other day in both eyes using a
TonoLab tonometer.
Statistical Analyses
Data are presented as means ± SEM. We used Student’s t test for two group
comparisons and one-way analysis of variance and Tukey’s multiple compar-
ison test for multiple comparisons.
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